The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): £50m
Expected first date of trading: 25/09/2012
Market: AIM
Location of address at which admission document will be available: From the registered office of the Company: Clinigen Group plc Pitcairn House Crown Square Centrum 100 Burton-on-Trent Staffordshire DE14 2WW From the offices of Numis Securities Limited: Numis Securities Limited The London Stock Exchange Building 10 Paternoster Square London EC4M 7LT The admission document will also be available for download at http://www.clinigengroup.com/ The admission document will contain full details regarding the applicant and the admission of its securities.
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Numis Securities Limited
Nominated Broker (AIM Companies): Numis Securities Limited
Financial PR Advisors: -

Company details
Name Role
Peter Vance Allen Non-Executive Chairman
Peter Lutz George Chief Executive Officer
Robin Andrew John Sibson Chief Financial Officer
John Hartup Non-Executive Director
Ian James Nicholson Non Executive Director

Facts and Figures
Fiscal year end: 30 June
Incorporated in: England
Website URL: http://www.clinigengroup.com/
space
Description of business:
Clinigen is a fast-growing global specialty pharmaceuticals and pharmaceutical services business dedicated to serving patients, the medical community and the healthcare industry. The Company currently employs 78 people across its operations and has a head office in Burton-on-Trent, UK, with further offices in Philadelphia, US and Tokyo, Japan. The Company’s primary country of operation is the U...

Person(s) interested:
Before Admission: Andrew Derrick Leaver and Linda Leaver 65.5% Peter Lutz George 12.5% Robin Andrew John Sibson 7.0% Anton Jonathan William Jenkins 5.0% After Admission: Andrew Derrick Leaver and Linda Leaver 33.0% Peter Lutz George 11.5% Robin Andrew John Sibson 6.4% Anton Jonathan William Jenkins 4.6%


Clinigen Group plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds